Skip to content
PeptideRank

Provider review

Alan Meds review

Every "$X/mo" headline requires paying 2-6 months upfront to get it.

Alan Meds' tirzepatide page headlines "Starting from $325/mo*," its semaglutide page headlines "$158/mo*" under a "Buy 1, Get 1 free" banner, and its sermorelin page headlines "$199/mo*" — every single asterisk resolves to the same footnote: "Paid upfront with a [2/3/6]-month plan." No product page on the entire site publishes a true no-commitment monthly rate.

Verified August 2026

Transparency scorecard

1 of 4 disclosed openly

What Alan Meds discloses about itself, read from its own pages — not estimated.

Pharmacy named & regulated

Not disclosed

Does not name a pharmacy or state a regulatory category anywhere on its own site.

State coverage published

Not disclosed

Publishes no state coverage list — availability is something you learn during signup.

A real price is published

Disclosed

A real dollar figure is published on its own site, not estimated.

No hidden commitment trap

Not disclosed

The advertised price requires a prepay, auto-refill, or other commitment we found and named.

This review's stake, stated plainly some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

On this page

What it actually costs

Medium confidence

What they advertise

Tirzepatide: "Starting from $325/mo*" (6-month prepay). Semaglutide: "$158/mo*" (2-month prepay, "Buy 1, Get 1 free"). Sermorelin: "$199/mo*" (3-month prepay). NAD+: "Starting from $235/mo*" (2-month prepay). Glutathione: "Starting from $155/mo*" (6-month prepay).

What you actually pay, month to month

No true no-commitment monthly price is published for any product. Where a "Regular price" is disclosed alongside the promo, it is dramatically higher: semaglutide's disclosed "Regular price" is $315 (vs. the $158/mo headline), sermorelin's is $295 (vs. $199/mo).

The commitment trap

Every product page's "$X/mo" headline is not a monthly billing rate at all — it is a multi-month total (2, 3, or 6 months, depending on the product) divided by the number of months and displayed as if it were the standing monthly charge, disclosed only in a small footnote asterisk.

Checked live on Alan Meds's own site at https://www.alanmeds.com/medications/personalized-compounded-tirzepatide in August 2026. Prices change without notice — confirm before you buy. Every figure here was read off Alan Meds's own public pages on the date shown, not from a third-party comparison table.

The bottom line

Alan Meds (alanmeds.com, legal entity Alan Health Technologies Inc.) is a real, live telehealth company selling compounded tirzepatide, semaglutide, sermorelin, NAD+, and glutathione — five boards, plus a separate brand-name Mounjaro/Zepbound/Wegovy/Ozempic line. Every compounded product uses the identical prepay-headline mechanism this review documents.

Alan Meds appears on our sermorelin provider ranking, our tirzepatide provider ranking, our semaglutide provider ranking, our NAD+ provider ranking, our Glutathione provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.

Who it is for, and who it is not

A good fit if

  • You're comfortable prepaying 2-6 months upfront to unlock the advertised rate, and you'd rather see that requirement stated in a footnote than hidden entirely.
  • You want five tracked compounds, plus microdosing and oral formats, from one company.
  • You want a physician-guided dosing plan reviewed on every product page before you commit.

Look elsewhere if

  • You want a true no-commitment monthly price — none is published anywhere on the site for any of its five compounds; every headline number requires a multi-month prepay to actually get.
  • You want a consistent, sourced pharmacy category — its tirzepatide page's own structured product data says "503a" while the same page's visible FAQ text says "503B," and no specific pharmacy is named anywhere.
  • You want a published state-coverage list — none exists; the Terms only say service is limited to "certain states," checked during signup.

What is included

The cheapest headline number in this category is often the one with the least attached to it. Here is what Alan Meds bundles in, and what it does not.

Clinician consult

Included

— every product page describes a licensed-provider dosing review as part of the plan.

Bloodwork / labs

Not stated on the pages checked.

Follow-ups and dose changes

Not stated on the pages checked.

Human support

Not stated on the pages checked.

Injection supplies

Not stated on the pages checked.

Shipping

Not stated on the pages checked.

Also sells

Beyond what this board tracks, Alan Meds's own site names these additional compounds — read live off the same product pages, not inferred.

  • NAD+Starting from $235/mo (2-month prepay)
  • GlutathioneStarting from $155/mo (6-month prepay)

Who fills it, and who's watching

The pharmacy

Unknown — self-contradicting. Alan Meds' own tirzepatide page states "503a Compounded Medication" in its structured product data, while the same page's visible FAQ text states "We only work with FDA-registered 503B outsourcing facilities." Its semaglutide page hedges both categories in structured data ("503a + 503b") while its own FAQ names only 503B. No specific pharmacy is named anywhere on the site.

Oversight

Included — every product page describes a licensed-provider dosing review as part of the plan. Not stated on the pages checked.

Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not.

Where you can get it

Not published. Alan Meds' own Terms and Conditions state services are "for use only by persons located in the United States" and available only in "certain states," with no list published anywhere on the site.

The honest cons

The part they would rather you skipped

Every one of Alan Meds' five compounded products displays a "$X/mo" headline that its own footnote discloses is really a multi-month prepay total: 6 months for tirzepatide and glutathione, 3 months for sermorelin, 2 months for semaglutide and NAD+. No product page anywhere on the site publishes a true no-commitment monthly rate — a reader who wants to pay one month at a time has to guess at the real cost. Where a "Regular price" is disclosed for comparison, it runs 48%-100% above the headline number. A second, independently-found finding: its own tirzepatide page's machine-readable structured data (JSON-LD) disagrees with its own visible FAQ text about which federal regulatory category the medication falls under ("503a" vs. "503B") — a same-page, self-contradicting claim about its own pharmacy sourcing, not just a hedge. No FDA warning letter could be independently confirmed at fda.gov this round — its own automated-request challenge blocked every attempt, WebSearch budget was exhausted before this task started, and DuckDuckGo/Bing/Google all blocked or returned unusable results to a direct fetch; noted honestly rather than presented as a clean check.

  • No product page on the site publishes a true no-commitment monthly price — every headline figure requires a 2-6 month prepay, disclosed only in a footnote.
  • Its own tirzepatide page's structured product data and visible FAQ text disagree on whether the medication is 503A or 503B compounded.
  • No state-coverage list is published anywhere on the site.

None of this is unique to Alan Meds — the whole category shares it.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Facts on this page reflect Alan Meds's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Alan Meds's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.